KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Raw Materials (2016 - 2022)

Bio-Rad Laboratories has reported Raw Materials over the past 14 years, most recently at $188.5 million for Q2 2022.

  • Quarterly Raw Materials rose 56.87% to $188.5 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $188.5 million through Jun 2022, up 56.87% year-over-year, with the annual reading at $116.9 million for FY2021, 7.9% down from the prior year.
  • Raw Materials was $188.5 million for Q2 2022 at Bio-Rad Laboratories, up from $146.2 million in the prior quarter.
  • Over five years, Raw Materials peaked at $188.5 million in Q2 2022 and troughed at $104.0 million in Q1 2020.
  • The 5-year median for Raw Materials is $118.3 million (2018), against an average of $123.3 million.
  • Year-over-year, Raw Materials dropped 18.41% in 2021 and then soared 56.87% in 2022.
  • A 5-year view of Raw Materials shows it stood at $108.0 million in 2018, then grew by 1.45% to $109.6 million in 2019, then grew by 15.83% to $126.9 million in 2020, then dropped by 7.9% to $116.9 million in 2021, then skyrocketed by 61.26% to $188.5 million in 2022.
  • Per Business Quant, the three most recent readings for BIO's Raw Materials are $188.5 million (Q2 2022), $146.2 million (Q1 2022), and $116.9 million (Q4 2021).